Document is current

Article History

Received: 30 July 2020

Accepted: 9 September 2020

First Online: 16 September 2020

Compliance with ethical standards

:

: TD reports grants and personal fees from Eli Lilly Japan, Kyowa Hakko Kirin, MSD, Daiichi Sankyo, Sumitomo Dainippon, Taiho, Novartis, Boehringer Ingelheim, Chugai Pharma, Bristol-Myers Squibb, Abbvie; personal fees from Bayer, Rakuten Medical, Ono Pharmaceutical, Astellas Pharma, Oncolys BioPharma, Amgen, Takeda; and grants from Merck Serono, Janssen, Pfizer, Quintiles, and Eisai. MT, JM, HA, and KI are employees of Eli Lilly Japan K.K. KB is a former employee of Eli Lilly and Company, current employee of Taiho Oncology, and holds Eli Lilly and Company stock. YN reports advisory roles for Eli Lilly and Company, Eisai, Chugai, Pfizer Inc., MSD, and AstraZeneca; lecturer fees from Novartis, Eisai, Chugai, Pfizer Inc., Kyowa Hakko Kirin Co., Ltd., FUJIFILM Toyama Chemical Co., Ltd.; research expenses from Roche; and presents or other payments from CI works, M3, and PhaseOne.

: Informed consent was obtained from all individual participants included in the study.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Not applicable.